{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:32:53Z","timestamp":1791999173552,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jinf.2016.02.017","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T13:30:16Z","timestamp":1458826216000},"page":"713-722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients"],"prefix":"10.1016","volume":"72","author":[{"given":"R.W.","family":"Wieten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Goorhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.F.F.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.","family":"de Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.W.","family":"de Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.J.","family":"van Genderen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.B.M.","family":"Remmerswaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.J.M.","family":"ten Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Grobusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.M.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2016.02.017_bib1","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(99)09233-8","article-title":"A haemorrhagic fever from the C\u00f4te d'Ivoire","volume":"354","author":"Teichmann","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2016.02.017_bib2","series-title":"Vaccines","first-page":"959","article-title":"Yellow fever vaccine","author":"Monath","year":"2008"},{"key":"10.1016\/j.jinf.2016.02.017_bib3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.13-0264","article-title":"Review article: efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years","volume":"89","author":"Gotuzzo","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jinf.2016.02.017_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/597006","article-title":"Immunogenicity and safety of yellow fever vaccination of 102 HIV infected patients","volume":"48","author":"Veit","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.02.017_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/QAI.0b013e318249de59","article-title":"Plasma HIV-RNA is the key determinant of long-term antibody persistence after yellow fever immunization in a cohort of 364 HIV infected patients","volume":"59","author":"Pacanowski","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2016.02.017_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.trstmh.2012.04.002","article-title":"Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in Mali","volume":"106","author":"Sidibe","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jinf.2016.02.017_bib7","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T-cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2016.02.017_bib8","series-title":"Dutch national guidelines on travellers' medicine","year":"2008"},{"key":"10.1016\/j.jinf.2016.02.017_bib9","unstructured":"CDC Yellow book http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2014\/chapter-8-advising-travelers-with-specific-needs\/immune-compromised-travelers [accessed September 05.09.15]."},{"key":"10.1016\/j.jinf.2016.02.017_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2016.01.037","article-title":"Comparison of the PRNT and an immune fluorescence assay in yellow fever vaccinees receiving immunosuppressive medication","author":"Wieten","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.02.017_bib11","first-page":"23","article-title":"Requirements for yellow fever vaccine","volume":"594","year":"1976","journal-title":"WHO Tech Rep Ser"},{"key":"10.1016\/j.jinf.2016.02.017_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jviromet.2005.08.001","article-title":"Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay","volume":"131","author":"Cohen","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jinf.2016.02.017_bib13","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.4049\/jimmunol.1202234","article-title":"Temporal dynamics of the primary human T-cell response to yellow fever virus 17D as it matures from an effector to a memory type response","volume":"190","author":"Blom","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2016.02.017_bib14","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1016\/j.vaccine.2008.08.019","article-title":"Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects","volume":"26","author":"Guy","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.02.017_bib15","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.1111\/j.1365-2567.2009.03070.x","article-title":"Dynamics of the CD8 T-cell response following yellow fever virus 17D immunization","volume":"128","author":"Co","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jinf.2016.02.017_bib16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Pillars article: two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2016.02.017_bib17","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ni1268","article-title":"Effector and memory CD8+ T-cell fate coupled by T-bet and eomesodermin","volume":"6","author":"Intlekofer","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jinf.2016.02.017_bib18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1126\/science.1090148","article-title":"Control of effector CD8+ T-cell function by the transcription factor Eomesodermin","volume":"302","author":"Pearce","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jinf.2016.02.017_bib19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1126\/science.1065543","article-title":"Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T-cells","volume":"295","author":"Szabo","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jinf.2016.02.017_bib20","doi-asserted-by":"crossref","first-page":"10017","DOI":"10.1128\/JVI.01083-08","article-title":"Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T-cells","volume":"82","author":"Badr","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2016.02.017_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm0402-379","article-title":"Memory CD8+ T-cells vary in differentiation phenotype in different persistent virus infections","volume":"8","author":"Appay","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2016.02.017_bib22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.1402605","article-title":"CD8+ T-cells complement antibodies in protecting against yellow fever virus","volume":"194","author":"Bassi","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2016.02.017_bib23","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/cyto.a.20643","article-title":"Phenotype and function of human T lymphocyte subsets: consensus and issues","volume":"73","author":"Appay","year":"2008","journal-title":"Cytometry A"},{"key":"10.1016\/j.jinf.2016.02.017_bib24","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.186.9.1407","article-title":"Phenotypic and functional separation of memory and effector human CD8+ T-cells","volume":"186","author":"Hamann","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.jinf.2016.02.017_bib25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/eji.201344269","article-title":"Blood and beyond: properties of circulating and tissue-resident human virus-specific \u03b1\u03b2 CD8(+) T-cells","volume":"44","author":"van Aalderen","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jinf.2016.02.017_bib26","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1182\/blood-2002-08-2502","article-title":"Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T-cells in protection against CMV disease","volume":"101","author":"Gamadia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2016.02.017_bib27","doi-asserted-by":"crossref","first-page":"e1004622","DOI":"10.1371\/journal.ppat.1004622","article-title":"Specificity and dynamics of effector and memory CD8 T-cell responses in human tick-borne encephalitis virus infection","volume":"11","author":"Blom","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jinf.2016.02.017_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2249.2002.01819.x","article-title":"A reduction in the number of peripheral CD28+CD8+T-cells in the acute phase of influenza","volume":"128","author":"Nabeshima","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2016.02.017_bib29","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.20051365","article-title":"Selective accumulation of differentiated CD8+ T-cells specific for respiratory viruses in the human lung","volume":"202","author":"de Bree","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jinf.2016.02.017_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/80868","article-title":"Interleukin-7 mediates the homeostasis of naive and memory CD8 T-cells in\u00a0vivo","volume":"1","author":"Schluns","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jinf.2016.02.017_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10875-008-9267-3","article-title":"Human immune memory to yellow fever and smallpox vaccination","volume":"29","author":"Wrammert","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jinf.2016.02.017_bib32","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1038\/cti.2014.16","article-title":"Stem memory T-cells (TSCM)- their role in cancer and HIB immunotherapies","volume":"3","author":"Flynn","year":"2014","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.jinf.2016.02.017_bib33","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T-cell subset with stem cell-like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2016.02.017_bib34","first-page":"594","article-title":"Superior T memory stem cell persistence supports long-lived T-cell memory","volume":"123","author":"Lugli","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jinf.2016.02.017_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3700","article-title":"Long lasting stem cell-like memory CD8+ T-cells with a na\u00efve like profile upon yellow fever vaccination","volume":"7","author":"Fuertes Marraco","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jinf.2016.02.017_bib36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316000827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316000827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:23:10Z","timestamp":1759008190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445316000827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0163445316000827"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2016.02.017","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2016.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}